Early life respiratory viral infections shape immune development trajectories
生命早期呼吸道病毒感染塑造免疫发育轨迹
基本信息
- 批准号:10435211
- 负责人:
- 金额:$ 169万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2022-12-19
- 项目状态:已结题
- 来源:
- 关键词:2019-nCoVATAC-seqAcuteAddressAffectAntibodiesAntibody ResponseAntibody titer measurementAntigensB-LymphocytesBloodBlood CellsCD8-Positive T-LymphocytesCOVID-19 vaccinationCOVID-19 vaccineCell NucleusCell surfaceCellsCellular AssayCellular Indexing of Transcriptomes and Epitopes by SequencingChildDevelopmentDiseaseEpigenetic ProcessEpitopesEvaluationEvolutionExposure toGenesGenetic TranscriptionHospitalizationImmuneImmune responseImmune systemImmunityImmunophenotypingIndividualInfantInfectionInfluenzaInfluenza vaccinationLeadLearningLifeLongitudinal cohortMorbidity - disease rateMultivariate AnalysisParticipantPatternPattern recognition receptorPeripheral Blood Mononuclear CellPhenotypeProductionResearch Project GrantsSARS-CoV-2 infectionShapesSpecificityVaccinationVaccinesViral Respiratory Tract InfectionVirusVirus Diseasesacute infectioncytokinedesigndroplet sequencingepigenomehigh risk populationimprintimprovedinfant infectioninfluenza infectioninfluenzavirusmortalitymultidimensional datarespiratory virusresponseseasonal influenzatranscriptome
项目摘要
Abstract
Viral respiratory infections are responsible for major morbidity and mortality in early life. Infants account for a
significant proportion of influenza hospitalizations and are considered a top high-risk group. In addition to the
acute morbidity, initial immune responses to influenza shape/imprint the immune system and affect subsequent
responses to influenza infections and vaccinations, which tend to induce humoral responses skewed towards
epitopes present in the first influenza antigen encountered. In contrast, SARS-CoV-2 infection in infants is
generally mild and less severe than in older individuals. This is remarkable and suggests that there are unique
features on how the infant immune system responds to SARS-CoV-2, compared to its responses against other
respiratory viruses, that can be leveraged to improve our understanding of early life immunity.
On the basis of these observations, we hypothesize that early life viral respiratory infections elicit virus-specific
immune responses that lead to distinct immune developmental trajectories. To address this hypothesis, we will
compare three longitudinal cohorts: i) infants infected with SARS-CoV-2; ii) infants infected with influenza virus;
and as reference iii) healthy infants with none of those two infections. After acute infection children will be
followed longitudinally for three years and immune responses assessed in the context of influenza and COVID-
19 vaccinations.
We designed two integrated research projects, supported by three cores. Project 1 will define: 1) the differences
of blood transcriptional immune signatures in infants with SARS-CoV-2 versus infants with influenza infection;
2) the magnitude, immunodominance pattern and breath of the antibody responses to influenza virus and
evolution of antibody responses to SARS-CoV-2; and 3) perform high-throughput longitudinal evaluation of B
cell responses to influenza and SARS-CoV-2. Project 2 will: 1) Assess the blood cell composition, transcriptome
and epigenome in response to influenza and SARS-CoV-2 infection occurring in the first six months of life at the
single cell level; and 2) Characterize the PBMC phenotype/cell composition, transcriptome and epigenome in
response to vaccination against influenza and SARS-CoV-2.
抽象的
病毒呼吸道感染负责早期的主要发病率和死亡率。婴儿解释
流感住院的很大比例,被认为是高风险群体。除了
急性发病率,对流感形状/烙印免疫系统的初始免疫反应,并影响随后的
对流感感染和疫苗接种的反应,这些感染和疫苗接种倾向于引起体液反应
遇到的第一个流感抗原中存在的表位。相反,婴儿的SARS-COV-2感染是
通常比老年人轻度且不那么严重。这很了不起,表明有独特的
与其他针对其他的反应相比,婴儿免疫系统如何对SARS-COV-2响应
可以利用的呼吸道病毒来提高我们对早期免疫力的理解。
根据这些观察,我们假设早期生命病毒呼吸道感染引起了病毒特异性
免疫反应会导致不同的免疫发育轨迹。为了解决这一假设,我们将
比较三个纵向队列:i)感染SARS-COV-2的婴儿; ii)感染流感病毒的婴儿;
作为参考III)这两种感染的健康婴儿。急性感染后的孩子将
紧随其后的三年,并在流感和互联的背景下评估了免疫反应
19次疫苗接种。
我们设计了两个综合研究项目,并得到了三个核心的支持。项目1将定义:1)差异
患有SARS-COV-2的婴儿与流感感染的婴儿的血液转录免疫信号;
2)对流感病毒和
对SARS-COV-2的抗体反应的演变; 3)对B进行高通量纵向评估
细胞对流感和SARS-COV-2的反应。项目2将:1)评估血细胞组成,转录组
和表观基因组对流感和SARS-COV-2感染的反应在生命的前六个月发生
单细胞水平; 2)表征PBMC表型/细胞组成,转录组和表观基因组
对疫苗接种疫苗和SARS-COV-2的反应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maria Virginia Pascual其他文献
Maria Virginia Pascual的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maria Virginia Pascual', 18)}}的其他基金
Early life respiratory viral infections shape immune development trajectories
生命早期呼吸道病毒感染塑造免疫发育轨迹
- 批准号:
10599202 - 财政年份:2022
- 资助金额:
$ 169万 - 项目类别:
Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
导致人类系统性自身免疫的免疫细胞和分泌途径
- 批准号:
10402544 - 财政年份:2021
- 资助金额:
$ 169万 - 项目类别:
Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
导致人类系统性自身免疫的免疫细胞和分泌途径
- 批准号:
10209399 - 财政年份:2020
- 资助金额:
$ 169万 - 项目类别:
Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
导致人类系统性自身免疫的免疫细胞和分泌途径
- 批准号:
10265722 - 财政年份:2020
- 资助金额:
$ 169万 - 项目类别:
Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
导致人类系统性自身免疫的免疫细胞和分泌途径
- 批准号:
9906169 - 财政年份:2019
- 资助金额:
$ 169万 - 项目类别:
Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
导致人类系统性自身免疫的免疫细胞和分泌途径
- 批准号:
10617208 - 财政年份:2019
- 资助金额:
$ 169万 - 项目类别:
相似国自然基金
面向图神经网络ATAC-seq模体识别的最小间隔单细胞聚类研究
- 批准号:62302218
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:82260745
- 批准年份:2022
- 资助金额:33.00 万元
- 项目类别:地区科学基金项目
基于ATAC-seq策略挖掘穿心莲基因组中调控穿心莲内酯合成的增强子
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:32100438
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
基于单细胞ATAC-seq技术的C4光合调控分子机制研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
COVID-19 imprints airway basal cells to impair epithelium regeneration
COVID-19 印记气道基底细胞,损害上皮再生
- 批准号:
10738549 - 财政年份:2023
- 资助金额:
$ 169万 - 项目类别:
Early life respiratory viral infections shape immune development trajectories
生命早期呼吸道病毒感染塑造免疫发育轨迹
- 批准号:
10599202 - 财政年份:2022
- 资助金额:
$ 169万 - 项目类别:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
研究项目1:表观遗传和转录机制在埃博拉病毒疾病发病机制中的作用
- 批准号:
10602491 - 财政年份:2021
- 资助金额:
$ 169万 - 项目类别:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
研究项目1:表观遗传和转录机制在埃博拉病毒疾病发病机制中的作用
- 批准号:
10188759 - 财政年份:2021
- 资助金额:
$ 169万 - 项目类别:
Research Project 1: Role of Epigenetic and Transcriptional Mechanisms in the Pathogenesis of Ebola Virus Disease
研究项目1:表观遗传和转录机制在埃博拉病毒疾病发病机制中的作用
- 批准号:
10394319 - 财政年份:2021
- 资助金额:
$ 169万 - 项目类别: